share_log

康弘药业:2023年度独立董事述职报告(邓宏光)

Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Deng Hongguang)

SZSI ·  Apr 25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more